Kenney Richard T Insider Trades

Insider Trading History

Track insider trading activity for Kenney Richard T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $206k 163,760 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 250,265 shares
$1.26
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $87.7k 69,614 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.3k 16,891 shares
$1.26
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 86,705 shares
$1.16
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$709k 562,748 shares
$1.26
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $403k 320,000 shares
Last Trade
Jul 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.09M 320,200 shares
$9.64
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $11.8k 9,374 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.4k 8,000 shares
$5.17
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $109k 86,505 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 86,505 shares
$1.16
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $1.73k 1,374 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 1,271 shares
$11.59
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $4.5k 3,571 shares
Last Trade
Jan 07, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.32M 14,627 shares
$226.81
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $22.9k 18,198 shares
Last Trade
Jan 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.32M 14,627 shares
$226.81
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $81.4k 64,627 shares
Last Trade
Dec 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.57M 14,627 shares
$175.82
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $63k 50,000 shares
Last Trade
Jun 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.5M 15,000 shares
$3,766.15
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $44.1k 35,000 shares
Last Trade
May 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.2M 10,000 shares
$3,815.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Medical Officer
Holding Value $31.5k 25,000 shares
Last Trade
Mar 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146M 25,000 shares
$5,858.46
$1.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up